【調査レポート】世界のエベロリムスAPI市場2023年：企業・地域・種類・用途別分析

• 英文タイトル：Global Everolimus API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のエベロリムスAPI市場2023年：企業・地域・種類・用途別分析 / Global Everolimus API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC308GR10040資料のイメージです。

• レポートコード：MRC308GR10040
• 出版社/出版日：GlobalInfoResearch / 2023年8月
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（2-3営業日）
• 産業分類：医療機器＆消耗品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥783,000 (USD5,220)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

GlobalInfoResearchの最新の調査によると、世界のエベロリムスAPIの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のエベロリムスAPI市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– エベロリムスAPIの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

エベロリムスAPI市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・純度≧99%、純度<99% 用途別セグメント・錠剤、分散錠主要な市場プレーヤー・BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD、BIOCON LTD、DR REDDYS LABORATORIES LTD、FARMHISPANIA SA、CKD BIO CORP、APOTEX PHARMACHEM INC、NATCO PHARMA LTD、SYNTHON BV、CKD BIO CORPORATION、CONCORD BIOTECH LTD、CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD、CHENGDU YACHT BIO-TECHNOLOGY CO LTD、HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD 地域別セグメントは次の地域・国をカバーします。・北米（米国、カナダ、メキシコ）・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）・南アメリカ（ブラジル、アルゼンチン、コロンビア）・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）本調査レポートの内容は計15章あります。・第1章では、エベロリムスAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。・第2章では、主要なエベロリムスAPIメーカーの企業概要、2019年～2022年までのエベロリムスAPIの価格、販売量、売上、市場シェアを掲載しています。・第3章では、主要なエベロリムスAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。・第4章では、2018年～2029年までの地域別エベロリムスAPIの販売量、売上、成長性を示しています。・第5、6章では、2018年～2029年までのエベロリムスAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのエベロリムスAPI市場予測を収録しています。・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。・第13章では、主要な原材料、主要なサプライヤー、およびエベロリムスAPIの産業チェーンを掲載しています。・第14、15章では、エベロリムスAPIの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - エベロリムスAPIの概要 - 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99% - 用途別分析（2018年vs2022年vs2029年）：錠剤、分散錠 - 世界のエベロリムスAPI市場規模・予測 - 世界のエベロリムスAPI生産能力分析 - 市場の成長要因・阻害要因・動向・メーカー情報（企業概要、製品概要、販売量、価格、売上） - BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD、BIOCON LTD、DR REDDYS LABORATORIES LTD、FARMHISPANIA SA、CKD BIO CORP、APOTEX PHARMACHEM INC、NATCO PHARMA LTD、SYNTHON BV、CKD BIO CORPORATION、CONCORD BIOTECH LTD、CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD、CHENGDU YACHT BIO-TECHNOLOGY CO LTD、HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD ・メーカー別市場シェア・市場集中度・地域別市場分析2018年-2029年・種類別分析2018年-2029年：純度≧99%、純度<99% ・用途別分析2018年-2029年：錠剤、分散錠・エベロリムスAPIの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど・エベロリムスAPIのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど・エベロリムスAPIのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど・エベロリムスAPIの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど・エベロリムスAPIの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）・原材料および産業チェーン・販売チャネル、流通業者・代理店、顧客リスト・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Everolimus API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Everolimus API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99% 1.4 Market Analysis by Application 1.4.1 Overview: Global Everolimus API Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Tablets 1.4.3 Dispersible Tablets 1.5 Global Everolimus API Market Size & Forecast 1.5.1 Global Everolimus API Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Everolimus API Sales Quantity (2018-2029) 1.5.3 Global Everolimus API Average Price (2018-2029) 2 Manufacturers Profiles 2.1 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD 2.1.1 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Details 2.1.2 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Major Business 2.1.3 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Everolimus API Product and Services 2.1.4 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Recent Developments/Updates 2.2 BIOCON LTD 2.2.1 BIOCON LTD Details 2.2.2 BIOCON LTD Major Business 2.2.3 BIOCON LTD Everolimus API Product and Services 2.2.4 BIOCON LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 BIOCON LTD Recent Developments/Updates 2.3 DR REDDYS LABORATORIES LTD 2.3.1 DR REDDYS LABORATORIES LTD Details 2.3.2 DR REDDYS LABORATORIES LTD Major Business 2.3.3 DR REDDYS LABORATORIES LTD Everolimus API Product and Services 2.3.4 DR REDDYS LABORATORIES LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates 2.4 FARMHISPANIA SA 2.4.1 FARMHISPANIA SA Details 2.4.2 FARMHISPANIA SA Major Business 2.4.3 FARMHISPANIA SA Everolimus API Product and Services 2.4.4 FARMHISPANIA SA Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 FARMHISPANIA SA Recent Developments/Updates 2.5 CKD BIO CORP 2.5.1 CKD BIO CORP Details 2.5.2 CKD BIO CORP Major Business 2.5.3 CKD BIO CORP Everolimus API Product and Services 2.5.4 CKD BIO CORP Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 CKD BIO CORP Recent Developments/Updates 2.6 APOTEX PHARMACHEM INC 2.6.1 APOTEX PHARMACHEM INC Details 2.6.2 APOTEX PHARMACHEM INC Major Business 2.6.3 APOTEX PHARMACHEM INC Everolimus API Product and Services 2.6.4 APOTEX PHARMACHEM INC Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 APOTEX PHARMACHEM INC Recent Developments/Updates 2.7 NATCO PHARMA LTD 2.7.1 NATCO PHARMA LTD Details 2.7.2 NATCO PHARMA LTD Major Business 2.7.3 NATCO PHARMA LTD Everolimus API Product and Services 2.7.4 NATCO PHARMA LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 NATCO PHARMA LTD Recent Developments/Updates 2.8 SYNTHON BV 2.8.1 SYNTHON BV Details 2.8.2 SYNTHON BV Major Business 2.8.3 SYNTHON BV Everolimus API Product and Services 2.8.4 SYNTHON BV Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 SYNTHON BV Recent Developments/Updates 2.9 CKD BIO CORPORATION 2.9.1 CKD BIO CORPORATION Details 2.9.2 CKD BIO CORPORATION Major Business 2.9.3 CKD BIO CORPORATION Everolimus API Product and Services 2.9.4 CKD BIO CORPORATION Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 CKD BIO CORPORATION Recent Developments/Updates 2.10 CONCORD BIOTECH LTD 2.10.1 CONCORD BIOTECH LTD Details 2.10.2 CONCORD BIOTECH LTD Major Business 2.10.3 CONCORD BIOTECH LTD Everolimus API Product and Services 2.10.4 CONCORD BIOTECH LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 CONCORD BIOTECH LTD Recent Developments/Updates 2.11 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD 2.11.1 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Details 2.11.2 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Major Business 2.11.3 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Everolimus API Product and Services 2.11.4 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Recent Developments/Updates 2.12 CHENGDU YACHT BIO-TECHNOLOGY CO LTD 2.12.1 CHENGDU YACHT BIO-TECHNOLOGY CO LTD Details 2.12.2 CHENGDU YACHT BIO-TECHNOLOGY CO LTD Major Business 2.12.3 CHENGDU YACHT BIO-TECHNOLOGY CO LTD Everolimus API Product and Services 2.12.4 CHENGDU YACHT BIO-TECHNOLOGY CO LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 CHENGDU YACHT BIO-TECHNOLOGY CO LTD Recent Developments/Updates 2.13 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD 2.13.1 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Details 2.13.2 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Major Business 2.13.3 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Everolimus API Product and Services 2.13.4 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Everolimus API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Recent Developments/Updates 3 Competitive Environment: Everolimus API by Manufacturer 3.1 Global Everolimus API Sales Quantity by Manufacturer (2018-2023) 3.2 Global Everolimus API Revenue by Manufacturer (2018-2023) 3.3 Global Everolimus API Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Everolimus API by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Everolimus API Manufacturer Market Share in 2022 3.4.2 Top 6 Everolimus API Manufacturer Market Share in 2022 3.5 Everolimus API Market: Overall Company Footprint Analysis 3.5.1 Everolimus API Market: Region Footprint 3.5.2 Everolimus API Market: Company Product Type Footprint 3.5.3 Everolimus API Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Everolimus API Market Size by Region 4.1.1 Global Everolimus API Sales Quantity by Region (2018-2029) 4.1.2 Global Everolimus API Consumption Value by Region (2018-2029) 4.1.3 Global Everolimus API Average Price by Region (2018-2029) 4.2 North America Everolimus API Consumption Value (2018-2029) 4.3 Europe Everolimus API Consumption Value (2018-2029) 4.4 Asia-Pacific Everolimus API Consumption Value (2018-2029) 4.5 South America Everolimus API Consumption Value (2018-2029) 4.6 Middle East and Africa Everolimus API Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Everolimus API Sales Quantity by Type (2018-2029) 5.2 Global Everolimus API Consumption Value by Type (2018-2029) 5.3 Global Everolimus API Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Everolimus API Sales Quantity by Application (2018-2029) 6.2 Global Everolimus API Consumption Value by Application (2018-2029) 6.3 Global Everolimus API Average Price by Application (2018-2029) 7 North America 7.1 North America Everolimus API Sales Quantity by Type (2018-2029) 7.2 North America Everolimus API Sales Quantity by Application (2018-2029) 7.3 North America Everolimus API Market Size by Country 7.3.1 North America Everolimus API Sales Quantity by Country (2018-2029) 7.3.2 North America Everolimus API Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Everolimus API Sales Quantity by Type (2018-2029) 8.2 Europe Everolimus API Sales Quantity by Application (2018-2029) 8.3 Europe Everolimus API Market Size by Country 8.3.1 Europe Everolimus API Sales Quantity by Country (2018-2029) 8.3.2 Europe Everolimus API Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Everolimus API Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Everolimus API Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Everolimus API Market Size by Region 9.3.1 Asia-Pacific Everolimus API Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Everolimus API Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Everolimus API Sales Quantity by Type (2018-2029) 10.2 South America Everolimus API Sales Quantity by Application (2018-2029) 10.3 South America Everolimus API Market Size by Country 10.3.1 South America Everolimus API Sales Quantity by Country (2018-2029) 10.3.2 South America Everolimus API Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Everolimus API Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Everolimus API Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Everolimus API Market Size by Country 11.3.1 Middle East & Africa Everolimus API Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Everolimus API Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Everolimus API Market Drivers 12.2 Everolimus API Market Restraints 12.3 Everolimus API Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Everolimus API and Key Manufacturers 13.2 Manufacturing Costs Percentage of Everolimus API 13.3 Everolimus API Production Process 13.4 Everolimus API Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Everolimus API Typical Distributors 14.3 Everolimus API Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer

List of Tables
Table 1. Global Everolimus API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Everolimus API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Basic Information, Manufacturing Base and Competitors
Table 4. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Major Business
Table 5. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Everolimus API Product and Services
Table 6. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Recent Developments/Updates
Table 8. BIOCON LTD Basic Information, Manufacturing Base and Competitors
Table 9. BIOCON LTD Major Business
Table 10. BIOCON LTD Everolimus API Product and Services
Table 11. BIOCON LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BIOCON LTD Recent Developments/Updates
Table 13. DR REDDYS LABORATORIES LTD Basic Information, Manufacturing Base and Competitors
Table 14. DR REDDYS LABORATORIES LTD Major Business
Table 15. DR REDDYS LABORATORIES LTD Everolimus API Product and Services
Table 16. DR REDDYS LABORATORIES LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DR REDDYS LABORATORIES LTD Recent Developments/Updates
Table 18. FARMHISPANIA SA Basic Information, Manufacturing Base and Competitors
Table 19. FARMHISPANIA SA Major Business
Table 20. FARMHISPANIA SA Everolimus API Product and Services
Table 21. FARMHISPANIA SA Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. FARMHISPANIA SA Recent Developments/Updates
Table 23. CKD BIO CORP Basic Information, Manufacturing Base and Competitors
Table 24. CKD BIO CORP Major Business
Table 25. CKD BIO CORP Everolimus API Product and Services
Table 26. CKD BIO CORP Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CKD BIO CORP Recent Developments/Updates
Table 28. APOTEX PHARMACHEM INC Basic Information, Manufacturing Base and Competitors
Table 29. APOTEX PHARMACHEM INC Major Business
Table 30. APOTEX PHARMACHEM INC Everolimus API Product and Services
Table 31. APOTEX PHARMACHEM INC Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. APOTEX PHARMACHEM INC Recent Developments/Updates
Table 33. NATCO PHARMA LTD Basic Information, Manufacturing Base and Competitors
Table 34. NATCO PHARMA LTD Major Business
Table 35. NATCO PHARMA LTD Everolimus API Product and Services
Table 36. NATCO PHARMA LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. NATCO PHARMA LTD Recent Developments/Updates
Table 38. SYNTHON BV Basic Information, Manufacturing Base and Competitors
Table 39. SYNTHON BV Major Business
Table 40. SYNTHON BV Everolimus API Product and Services
Table 41. SYNTHON BV Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. SYNTHON BV Recent Developments/Updates
Table 43. CKD BIO CORPORATION Basic Information, Manufacturing Base and Competitors
Table 44. CKD BIO CORPORATION Major Business
Table 45. CKD BIO CORPORATION Everolimus API Product and Services
Table 46. CKD BIO CORPORATION Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. CKD BIO CORPORATION Recent Developments/Updates
Table 48. CONCORD BIOTECH LTD Basic Information, Manufacturing Base and Competitors
Table 49. CONCORD BIOTECH LTD Major Business
Table 50. CONCORD BIOTECH LTD Everolimus API Product and Services
Table 51. CONCORD BIOTECH LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CONCORD BIOTECH LTD Recent Developments/Updates
Table 53. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Basic Information, Manufacturing Base and Competitors
Table 54. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Major Business
Table 55. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Everolimus API Product and Services
Table 56. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Recent Developments/Updates
Table 58. CHENGDU YACHT BIO-TECHNOLOGY CO LTD Basic Information, Manufacturing Base and Competitors
Table 59. CHENGDU YACHT BIO-TECHNOLOGY CO LTD Major Business
Table 60. CHENGDU YACHT BIO-TECHNOLOGY CO LTD Everolimus API Product and Services
Table 61. CHENGDU YACHT BIO-TECHNOLOGY CO LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. CHENGDU YACHT BIO-TECHNOLOGY CO LTD Recent Developments/Updates
Table 63. HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 64. HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Major Business
Table 65. HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Everolimus API Product and Services
Table 66. HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Everolimus API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 68. Global Everolimus API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 69. Global Everolimus API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Everolimus API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 71. Market Position of Manufacturers in Everolimus API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Everolimus API Production Site of Key Manufacturer
Table 73. Everolimus API Market: Company Product Type Footprint
Table 74. Everolimus API Market: Company Product Application Footprint
Table 75. Everolimus API New Market Entrants and Barriers to Market Entry
Table 76. Everolimus API Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Everolimus API Sales Quantity by Region (2018-2023) & (Tons)
Table 78. Global Everolimus API Sales Quantity by Region (2024-2029) & (Tons)
Table 79. Global Everolimus API Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Everolimus API Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Everolimus API Average Price by Region (2018-2023) & (US$/Ton)
Table 82. Global Everolimus API Average Price by Region (2024-2029) & (US$/Ton)
Table 83. Global Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Global Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Global Everolimus API Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Everolimus API Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Everolimus API Average Price by Type (2018-2023) & (US$/Ton)
Table 88. Global Everolimus API Average Price by Type (2024-2029) & (US$/Ton)
Table 89. Global Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 90. Global Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 91. Global Everolimus API Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Everolimus API Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Everolimus API Average Price by Application (2018-2023) & (US$/Ton)
Table 94. Global Everolimus API Average Price by Application (2024-2029) & (US$/Ton)
Table 95. North America Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 96. North America Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 97. North America Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 98. North America Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 99. North America Everolimus API Sales Quantity by Country (2018-2023) & (Tons)
Table 100. North America Everolimus API Sales Quantity by Country (2024-2029) & (Tons)
Table 101. North America Everolimus API Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Everolimus API Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 104. Europe Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 105. Europe Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 106. Europe Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 107. Europe Everolimus API Sales Quantity by Country (2018-2023) & (Tons)
Table 108. Europe Everolimus API Sales Quantity by Country (2024-2029) & (Tons)
Table 109. Europe Everolimus API Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Everolimus API Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 112. Asia-Pacific Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 113. Asia-Pacific Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 114. Asia-Pacific Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 115. Asia-Pacific Everolimus API Sales Quantity by Region (2018-2023) & (Tons)
Table 116. Asia-Pacific Everolimus API Sales Quantity by Region (2024-2029) & (Tons)
Table 117. Asia-Pacific Everolimus API Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Everolimus API Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 120. South America Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 121. South America Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 122. South America Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 123. South America Everolimus API Sales Quantity by Country (2018-2023) & (Tons)
Table 124. South America Everolimus API Sales Quantity by Country (2024-2029) & (Tons)
Table 125. South America Everolimus API Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Everolimus API Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Everolimus API Sales Quantity by Type (2018-2023) & (Tons)
Table 128. Middle East & Africa Everolimus API Sales Quantity by Type (2024-2029) & (Tons)
Table 129. Middle East & Africa Everolimus API Sales Quantity by Application (2018-2023) & (Tons)
Table 130. Middle East & Africa Everolimus API Sales Quantity by Application (2024-2029) & (Tons)
Table 131. Middle East & Africa Everolimus API Sales Quantity by Region (2018-2023) & (Tons)
Table 132. Middle East & Africa Everolimus API Sales Quantity by Region (2024-2029) & (Tons)
Table 133. Middle East & Africa Everolimus API Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Everolimus API Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Everolimus API Raw Material
Table 136. Key Manufacturers of Everolimus API Raw Materials
Table 137. Everolimus API Typical Distributors
Table 138. Everolimus API Typical Customers
List of Figures
Figure 1. Everolimus API Picture
Figure 2. Global Everolimus API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Everolimus API Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Everolimus API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Everolimus API Consumption Value Market Share by Application in 2022
Figure 8. Tablets Examples
Figure 9. Dispersible Tablets Examples
Figure 10. Global Everolimus API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Everolimus API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Everolimus API Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Everolimus API Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Everolimus API Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Everolimus API Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Everolimus API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Everolimus API Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Everolimus API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Everolimus API Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Everolimus API Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Everolimus API Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Everolimus API Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Everolimus API Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Everolimus API Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Everolimus API Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Everolimus API Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Everolimus API Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Everolimus API Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Everolimus API Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Everolimus API Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Everolimus API Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Everolimus API Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Everolimus API Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Everolimus API Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Everolimus API Consumption Value Market Share by Region (2018-2029)
Figure 52. China Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Everolimus API Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Everolimus API Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Everolimus API Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Everolimus API Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Everolimus API Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Everolimus API Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Everolimus API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Everolimus API Market Drivers
Figure 73. Everolimus API Market Restraints
Figure 74. Everolimus API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Everolimus API in 2022
Figure 77. Manufacturing Process Analysis of Everolimus API
Figure 78. Everolimus API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source

以下、関連資料のご紹介

世界のエベロリムス医薬品市場予測（～2028年）：2.5mg、5mg、7mg、10mg
Global Everolimus Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-23F2444 2023年2月 77Pages
...

世界の高純度ポリビニルアルコールPVA市場2023年：企業・地域・種類・用途別分析

Global High Purity Polyvinyl Alcohol PVA Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z0866 2023年9月 75Pages
GlobalInfoResearchの最新の調査によると、世界の高純度ポリビニルアルコールPVAの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計し...

世界の高純度1,3-ジクロロ-2-プロパノール市場2023年：企業・地域・種類・用途別分析

Global High Purity 1,3-Dichloro-2-Propanol Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z0842 2023年9月 77Pages
GlobalInfoResearchの最新の調査によると、世界の高純度1,3-ジクロロ-2-プロパノールの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模...

世界の高純度二ケイ化物粉末市場2023年：企業・地域・種類・用途別分析

Global High Purity Disilicide Powder Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z0855 2023年9月 91Pages
GlobalInfoResearchの最新の調査によると、世界の高純度二ケイ化物粉末の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

世界の高純度1,6-ヘキサンジオール市場2023年：企業・地域・種類・用途別分析

Global High Purity 1,6-Hexanediol Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z0844 2023年9月 90Pages
GlobalInfoResearchの最新の調査によると、世界の高純度1,6-ヘキサンジオールの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しま...